Rchr
J-GLOBAL ID：201701016110068845   Update date: Nov. 18, 2024

Fujiwara Kei

Fujiwara Kei
Affiliation and department：
Nagoya City University Graduate School of Medical Sciences Department of Gastroenterology and Metabolism

About Nagoya City University Graduate School of Medical Sciences Department of Gastroenterology and Metabolism


Job title： Associate Professor
Research field  (1)： Gastroenterology
Research theme for competitive and other funds  (3)：
  • 2019 - 2023 HBV遺伝子のヒト遺伝子への組み込みに対する統合的遺伝子解析から肝発癌を予測する
  • 2013 - 2017 Development of method to detect four mRNAs of hepatitis B virus in liver tissue
  • 2012 - 2016 The new therapy of liver cirrhosis which inhibit the progression fibrosis
Papers (94)：
  • Takanori Suzuki, Kentaro Matsuura, Takako Inoue, Hayato Kawamura, Kei Fujiwara, Hiromi Kataoka, Yasuhito Tanaka. Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs. Hepatology Research. 2024
  • Daisuke Kato, Takanori Suzuki, Kentaro Matsuura, Kohei Okayama, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Katsumi Hayashi, Atsunori Kusakabe, Izumi Hasegawa, et al. Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study. Oncology. 2024. 1-9
  • Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Sho Matoya, Tomokatsu Miyaki, Yoshihide Kimura, Atsunori Kusakabe, et al. Serum interleukin-6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis. Journal of gastroenterology and hepatology. 2024. 39. 10. 2158-2168
  • Maria Buti, Jeong Heo, Yasuhito Tanaka, Pietro Andreone, Masanori Atsukawa, Joaquín Cabezas, Eric Chak, Carla S Coffin, Kei Fujiwara, Natalya Gankina, et al. Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B. Journal of hepatology. 2024
  • Takanori Suzuki, Kentaro Matsuura, Takako Inoue, Keiko Sasada, Shintaro Ogawa, Takehisa Watanabe, Hayato Kawamura, Kei Fujiwara, Hiromi Kataoka, Yasuhito Tanaka. Clinical performance of Circulating HBV RNA and iTACT-HBcrAg Assays in HBeAg-negative and HBsAg-cleared Chronic Hepatitis B Patients. Journal of Medical Virology. 2024. 96. 7
ｍore...
MISC (49)：
ｍore...
Books (3)：
  • Human Viruses: Diseases, Treatments and Vaccines
    Springer International Publishing 2021
  • がん治療のフロンティア
    中日新聞社 2020 ISBN:9784806207719
  • ウイルス肝炎update
    中外医学社 2005 ISBN:4498042905
Lectures and oral presentations  (9)：
  • B型肝炎
    (令和5 年度愛知県肝疾患診療連携拠点病院・専門医療機関等連絡協議会(兼 愛知県肝炎診療従事者等研修会) 2024)
  • L’interféron pégylé réduit les rechutes après traitement par Bepirovirsen chez les patients atteints d’une infection chronique par le virus de l’hépatite B sous analogues nucléos(t)idiques : résultats de fin de l’étude de phase 2b B-Together
    (Societe Nationale Francaise de Gastro-Enterologie - JFHOD 2024)
  • Pegylated interferon reduces relapses following bepirovirsen treatment in participants with chronic hepatitis B virus infection on nucleos(t)ide analogs: end of study results from the Phase 2b B-Together study
    (AASLD The Liver Meeting 2023 2023)
  • 肝硬変の最新治療
    (令和4年度愛知県肝疾患診療連携拠点病院・専門医療機関等連絡協議会(兼 愛知県肝炎診療従事者等研修会) 2023)
  • 原因不明の肝障害・肝乏血性腫瘤の精査で判明した成人発症 2 型シトルリン血症の 1 例
    (日本内科学会東海支部主催第249回 東海地方会 (JP タワー名古屋 ホール&カンファレンス・Web) 2023)
ｍore...
Professional career (2)：
  • MD (Nagoya City University)
  • PhD (Nagoya City University Graduate School of Medical Sciences)
Committee career (1)：
  • 2020/06 - 現在 愛知県肝炎診療協議会 委員
Awards (1)：
  • 2013/10 - The Japan Society of Hepatology Crown Award, 6th CHUGAI Award
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM